Cita APA (7a ed.)

Y, S., S, N., M, N., H, T., & Y, K. (2015). Efficiency, safety, and patient preference of switching from dorzolamide 1%/timolol 0.5% to brinzolamide 1%/timolol 0.5% while maintaining the prostaglandin F2α analog. Dove Medical Press.

Cita Chicago Style (17a ed.)

Y, Shimizu, Nakakura S, Nishiyama M, Tabuchi H, y Kiuchi Y. Efficiency, Safety, and Patient Preference of Switching from Dorzolamide 1%/timolol 0.5% to Brinzolamide 1%/timolol 0.5% While Maintaining the Prostaglandin F2α Analog. Dove Medical Press, 2015.

Cita MLA (8a ed.)

Y, Shimizu, et al. Efficiency, Safety, and Patient Preference of Switching from Dorzolamide 1%/timolol 0.5% to Brinzolamide 1%/timolol 0.5% While Maintaining the Prostaglandin F2α Analog. Dove Medical Press, 2015.

Precaución: Estas citas no son 100% exactas.